Naso-orbito-ethmoidal fracture main cause of traumatic NLDO

Article

Naso-orbito-ethmoidal fracture has been discovered as the main cause of traumatic nasolacrimal duct obstruction (NLDO), according to a paper in the European Journal of Ophthalmology.

Naso-orbito-ethmoidal fracture has been discovered as the main cause of traumatic nasolacrimal duct obstruction (NLDO), according to a paper in the European Journal of Ophthalmology.

Dr Bipasha Mukherjee et al., Department of Orbit, Oculoplasty, Reconstructive, and Aesthetic Surgery, Medical Research Foundation, Sankara Nethralaya, Chennai, India, reviewed 28 patients in the study. They retrospectively analysed data of the nature and pattern of injury, associated damage, clinical features, investigations, management, outcome and follow-up.

The most common cause of traumatic NLDO was high-velocity blunt injury encountered in road traffic accidents in 70% of patients, with the most common pattern of injury being naso-orbital-ethmoidal fractures in 64% of patients. Traumatic telecanthus was most commonly linked to periocular injury.

Of the the patients investigated, 75% were analysed with computed tomography-dacryocystography. External dacryocystorhinostomy was used to treat26 patients with or without silicon intubation and 2 patients underwent dacryocystorhinostomy. General and local anaesthesia was given to 68% and 32% of patients, respectively.

There was a successful outcome recorded in 96% of eyes operated with external dacryocystorhinostomy with or without silicone intubation. Telecanthus is an important presenting feature in the patients, with naso-orbito-ethmoidal fracture as the main cause of traumatic NLDO.

For the abstract please visit this page.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.